| Free Shipping On Orders Over $60! (Within U.S.A.) | |
 |
GUN CONTROL IN NAZI-OCCUPIED FRANCE: Tyranny and Resistance By Stephen P. Halbrook |
 |
T.R.M. HOWARD: Doctor, Entrepreneur, Civil Rights Pioneer By David T. Beito, Linda Royster Beito |
 |
ELEVEN PRESIDENTS: Promises vs. Results in Achieving Limited Government By Ivan Eland |
 |
POPE FRANCIS AND THE CARING SOCIETY Edited By Robert M. Whaples |
 |
CHINA’S GREAT MIGRATION: How the Poor Built a Prosperous Nation By Bradley M. Gardner |
 |
CROSSROADS FOR LIBERTY: Recovering the Anti-Federalist Values of America’s First Constitution By William J. Watkins |
 |
FUTURE: Economic Peril or Prosperity? Edited By Christopher J. Coyne, Michael C. Munger, and Robert M. Whaples |
 |
FAILURE: The Federal Misedukation of America’s Children By Vicki E. Alger |
 |
NATURE UNBOUND: Bureaucracy vs. the Environment By Kenneth J. Sim, Randy Simmon, and Ryan M. Yonk |
 |
THE MIDAS PARADOX: Financial Markets, Government Policy Shocks, and the Great Depression By Scott Sumner |
Increased competition is the remedy to skyrocketing drug prices.
Tags: AARP, competition, Daraprim, EpiPen, FDA, Food and Drug Administration, Heather Bresch, market pricing, Martin Shkreli, Mylan, pharmaceuticals, Turing Pharmaceuticals
Late last year Turing Pharmaceuticals provoked a serious backlash after hiking the price of the pill Daraprim from $13.50 to $750 per pill. The head of the company defended his firm against the criticism, but many found his arguments lacking. While we may question the overnight price jump of more than 5,400 percent, economics...
Read More »
Tags: Daraprim, drug prices, medication, pharmaceutical industry, pharmaceutical prices, prescription drug prices
